Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
41,587,315
-
Total 13F shares
-
7,046,307
-
Share change
-
-6,254
-
Total reported value
-
$17,074,708
-
Price per share
-
$2.42
-
Number of holders
-
12
-
Value change
-
-$15,992
-
Number of buys
-
2
-
Number of sells
-
4
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q4 2022
As of 31 Dec 2022,
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,046,307 shares.
The largest 10 holders included
22NW, LP, LVW Advisors, LLC, Nantahala Capital Management, LLC, MANGROVE PARTNERS, Praetorian Capital Management LLC, Ikarian Capital, LLC, Herr Investment Group LLC, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., and Tower Research Capital LLC (TRC).
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.